The presence of an androgen receptor subdivided TNBC into quadruple-negative breast cancer and AR-positive TNBC, the latter of which harnessed a different dependency on the androgen receptor, which was more ubiquitously expressed than ER and PR (49, 50). The gene discussed is AR; the disease is breast cancer.